EQUR — E-Qure Share Price
Last trade - 00:00- $0.01m
- $0.16m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
E-Qure Corp. is a medical device company that is focused on commercializing its Bioelectrical Signal Therapy Device (BST Device). The BST Device is a non-invasive, painless and easy to use electrotherapy. The Company's non-invasive BST electrical transmission Device mimics the naturally occurring pulses of healing wounds (normal wounds) and creates an electric induction field around the hard-to-heal wound, which accelerates the healing rate. The BST Device stimulates renewed blood flow and oxygen to induce local cell regeneration and therefore promote wound healing. The BST Device is designed to treat chronic wounds, primarily Stage III and Stage IV ulcers. The BST Device is used for the treatment of chronic wounds that include diabetic foot ulcers, vascular (venous or arterial), leg ulcers and pressure (decubitus) ulcers. The BST Device can accelerate healing with rapid wound closure from 45 to 60 days.
Directors
- Ron Weissberg CHM (63)
- Ohad Goren CEO (48)
- Gal Peleg CFO (41)
- Itsik Ben Yesha CTO (67)
- Michael Sessler IND (60)
- Last Annual
- December 31st, 2020
- Last Interim
- September 30th, 2021
- Incorporated
- May 2nd, 2014
- Public Since
- July 11th, 2001
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 34,546,060
- Address
- 20 WEST 64TH STREET, SUITE 39G, NEW YORK, 10023
- Web
- https://www.e-qure.com/
- Phone
- +1 97254427777
- Auditors
- M&K CPAS PLLC
Upcoming Events for EQUR
Similar to EQUR
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Agape ATP
Pink Sheets on Nasdaq
FAQ
As of Today at 19:08 UTC, shares in E-Qure are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in E-Qure last closed at $0.00 and the price had moved by -99.05% over the past 365 days. In terms of relative price strength the E-Qure share price has underperformed the S&P500 Index by -99.17% over the past year.
There is no consensus recommendation for this security.
Find out moreE-Qure does not currently pay a dividend.
E-Qure does not currently pay a dividend.
E-Qure does not currently pay a dividend.
To buy shares in E-Qure you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in E-Qure had a market capitalisation of $0.01m.
Here are the trading details for E-Qure:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: EQUR
Based on an overall assessment of its quality, value and momentum E-Qure is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like E-Qure. Over the past six months, its share price has underperformed the S&P500 Index by -6.92%.
As of the last closing price of $0.00, shares in E-Qure were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The E-Qure PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
E-Qure's management team is headed by:
- Ron Weissberg - CHM
- Ohad Goren - CEO
- Gal Peleg - CFO
- Itsik Ben Yesha - CTO
- Michael Sessler - IND